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Summary 17 
Despite advances in in therapeutic interventions and supportive care, the morbidity 18 
and mortality associated with cancer has remained significant. Thus there is a need for newer 19 
and more powerful anti-tumour agents. The search for new anti-tumour compounds 20 
originating from natural resources is a promising research area. Animals living in polluted 21 
environments are a potent source of anti-tumour agents. Under polluted milieus, species such 22 
as crocodiles, feed on rotten meat, are exposed to heavy metals, endure high levels of 23 
radiation, are among the very few species to survive the catastrophic Cretaceous-Tertiary 24 
extinction event with a prolonged lifespan. Thus it is reasonable to speculate that animals 25 
such as crocodiles have developed mechanisms to defend themselves against cancer. The 26 
discovery of antitumor activity in animals such as crocodiles, whales, sharks, etc will 27 
stimulate research in finding therapeutic molecules from unusual sources, and has potential 28 
for the development of novel antitumor compound(s) that may also overcome current drug 29 
resistance. Nevertheless, intensive research in the next few years will be required to realize 30 
these expectations. 31 
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Introduction 36 
The morbidity and mortality associated with cancer has remained significant, despite 37 
advances in therapeutic interventions and supportive care. For example, the International 38 
Agency for Research on Cancer reports that in 2012, there were approximately 14.1 million 39 
new cancer cases, 32.6 million pre-existing cancer patients and 8.2 million deaths due to 40 
cancer worldwide [1]. By 2030, the global cancer burden is expected to almost double, 41 
growing to 21.7 million cases and 13 million deaths, , in part due to aging population [1-3]. 42 
Additionally, cancer cell dormancy and emergence of drug resistance contributes to poor 43 
prognosis, resulting in a high number of pre-existing cancer cases. Thus there is a continuous 44 
need to search for anti-cancer therapies.  45 
Natural products have been used widely for medicinal purposes. In particular, natural 46 
products derived from plants have led to the identification of anti-cancer agents such as Vinca 47 
alkaloids (e.g., Vincristine, Vinblastine) [4], Podophyllotoxin (PPT) derivatives (e.g., 48 
etoposide) [5] and Taxol derivatives (e.g., paclitaxel) [6] but drug resistance remains a major 49 
challenge and highlights the importance of new compounds. . Recently, we hypothesized that 50 
crocodiles possess anti-tumour compound(s) and/or mechanisms to counter cancer 51 
development [7]. The fact that animals such as crocodiles live in unhygienic conditions, feed 52 
on rotten meat, are exposed to heavy metals such as arsenic, cadmium, cobalt, chromium, 53 
mercury, nickel, lead, selenium, endure high levels of radiation, are among the very few 54 
species to survive the catastrophic Cretaceous-Tertiary extinction event [8-14], with a 55 
prolonged lifespan and rarely develop cancer suggest that they possess mechanisms to 56 
counter cancer development. Having visited several crocodile sanctuaries in South-East Asia 57 
and working together with expert veterinarians handling crocodiles/alligators over the past 58 
few decades, it was intriguing to note the absence of cancer development in these animals 59 
(personal communications with expert veterinarians, S. Vellayan, who dissected over 2000 60 
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crocodiles, post-mortem, and none showed cancer characteristics). This is corroborated with 61 
the absence of scientific evidence on cancer incidence rate in these species. Similarly, other 62 
animals such as whales, sharks, turtles, tortoises, elephants, snakes etc have long lifespan. 63 
Although the incidence rate of cancer is not available for several vertebrates, cancer has been 64 
reported in snakes [15[, tortoise [16], crocodile [17], monitor lizards [18], whales [19], and 65 
sharks [20]. Given the rarity of cancer development or associated complications together with 66 
their prolonged life span of up to a 100 years [14,21-23], it is reasonable to speculate that 67 
these animals may have developed protective mechanisms or possess bioactive molecules 68 
with anti-tumour  properties which may prevent them from developing cancer.   Here, we 69 
review the literature on the occurrence of anti-tumour compounds in animals living in 70 
polluted environments and the potential for future investigation in these species.    71 
Animal-based anti-cancer agents  72 
The discovery of anti-cancer agents from animals living in polluted environments is a 73 
worthy area of research that offers an untapped biological source for the isolation of novel 74 
anti-tumour molecules. Among mammals, animals such as elephants and whales are 75 
perceived to be highly resistant to cancer [21-23]. Being one of the oldest mammal which has 76 
existed since pre-historic times, whales have demonstrated their ability to survive evolution 77 
by adaptation [21-23]. For example, Bowhead whales (Balaena mysticetus) are able to live 78 
up to over 211 years [21-23]. Animals with large body size and longer lifespans were 79 
presumed to have an increased risk of developing cancer, if organisms possess similar 80 
malignant transformation risks and cancer suppression mechanisms when exposed to cancer 81 
causing agents. Therefore, since larger sized animals contain more cells, they were presumed 82 
to have a higher chance of developing cancer compared to smaller sized organisms [21-23]. 83 
Additionally, animals with longer lifespans were thought to have more time to mount up 84 
mutations caused by cancer causing agents compared to animals with shorter lifespan [21-85 
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23]. This concept was however proven wrong by Peto’s paradox. Cancer was shown to have 86 
no correlation with the body size and lifespan of an organism. The concept of Peto’s paradox 87 
explains the presence of lower oncogene (anti-apoptotic genes) expression and increase 88 
tumour suppressor genes in large, long lived animals [21]. As a result, active apoptosis 89 
activity within cells, prevents the proliferation or cell division of abnormal cells, leading to a 90 
lower chance of developing cancer. Besidesanimals such as elephants have lower metabolic 91 
rates, leading to reduced free radical accumulation. Additionally, elephants were found to 92 
produce ‘cheater’ tumour cells which parasitizes the growth of other tumour cells [21]. As a 93 
result, tumour cells are unable to grow leading to a reduced risk of developing cancer. 94 
Additional studies revealed the possible mechanisms which are involved in lower cancer 95 
development in bowhead whales and elephants compared to other mammals [21-23]. These 96 
animals possess altered gene expression levels which makes them  less likely to develop 97 
cancer in comparison to other species. The p53 tumour suppression gene activity was found 98 
to be highly expressed in elephants. A higher expression of tumour suppressor gene, 99 
increases cell sensitivity towards cancer causing agents, leading to the initiation of 'apoptosis 100 
of tumour cells. Elephants which are the evolved version of mammals from the 101 
Proboscideans family are also found to have a very low chance of developing cancer [21,23]. 102 
Studies have shown that the tumour suppressor gene, p53 in elephants was retro-duplicated. 103 
This retro-duplicated p53 was highly expressed in elephants leading to enhanced sensitivity 104 
of elephant cells towards genotoxic stress, resulting in induction of apoptosis [21]. Although 105 
the discovery of multiple p53 genes in elephants partially explains lower cancer risk in 106 
elephants and other large sized animals, the link between the p53 gene expression and cancer 107 
suppression as well as the presence of potential anti-tumour molecule(s) is yet to be 108 
determined.  109 
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Reptiles such as crocodiles are shown to contain many bioactive peptide which 110 
exhibits anti-inflammatory, anti-oxidative and anti-microbial characteristics [24-26]. Song et 111 
al., [27] showed that bile acids from crocodiles and snakes were found to contain anti-cancer 112 
properties. Furthermore, ESC-3 was shown to be the active component in crocodile bile that 113 
induced apoptosis in Mz-ChA-1 cells through the mitochondria-dependent pathway and it 114 
was proposed as a potential chemotherapeutic drug against cholangiocarcinoma [27]. This is 115 
consistent with Chinese Traditional Medicine where animal bile acids have been used in the 116 
treatment of various diseases including cancer [28]. In particular, Siamese crocodiles 117 
(Crocodylus siamensis) are one the most studied crocodile species in terms  for cancer 118 
research and their bile acids and white blood cell extracts were shown to exhibit anti-cancer 119 
properties [25-29]. In particular, bile acid extract inhibited proliferation of human biliary 120 
adenocarcinoma cells (Sk-ChA-1) and several other cholangiocarcinoma cells such as MZ-121 
ChA-1 [27] and QBC939 [29] and human hepatocellular carcinoma cells (SMMC7721) [30] 122 
in a dose-dependent manner. Molecular studies revealed that the proliferation of cancer cells 123 
were inhibited via the cell cycle arrest mechanism at the G0/G1 phase [228,29]. Later studies 124 
revealed that Siamese crocodile bile extracts induce apoptosis via production of reactive 125 
oxygen species, loss of mitochondrial membrane potential, resulting in the release of 126 
cytochrome c into the cytosol, up-regulation of pro-apoptotic proteins such as p53 and Bax, 127 
and down-regulation of anti-apoptotic proteins such as Bcl-2, Survivin and c-Myc [25-27]. In 128 
addition to cytotoxic effects of crocodile bile acids on human cells, bile acid extract was 129 
found to enhance the sensitivity of drug uptake by human cholangiocarcinoma multidrug 130 
resistance cell line (QBC939/5-FU) suggesting that molecular constituents of bile acid 131 
extracts of Siamese crocodiles can augment anti-cancer chemotherapeutic properties [31]. 132 
Notably, phase III trial of Ursodeoxycholic acid (UDCA) treatment, a component from 133 
normally present in bile fluid showed a 39% reduction in malignant tumours [29,32]. This is 134 
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in contrast to bile from humans where secondary bile acids were shown to play a role in 135 
intestinal tumour development [33] suggesting differences in composition of molecular 136 
constituents of bile in difference species. More recently, white blood cell extracts from 137 
Siamese crocodiles are shown to exhibit anti-angiogenic properties in cancer cells by 138 
inhibiting the expression of matrix metalloproteinase such as MMP2 and MMP9, suggesting 139 
the disruption of vascular endothelial growth factor (VEGF) and integrin-mediated signal 140 
transduction [24]. The disruption of MMP2, MMP9 and VEGF activity directly inhibits 141 
metastasis among cancer cells [24]. Patathananone et al., [24] demonstrated the anti-motility 142 
effects of Siamese crocodile white blood cell extracts against HeLa cells, mediated by 143 
disruption of Ras and p38 signalling pathway, however in vivo studies are needed to 144 
determine the translational value of these findings.   145 
Recently, our studies showed that the organ lysates of Crocodylus palustris exhibit 146 
antitumor activity against prostate cancer cells (PC3). Among various body organs of 147 
crocodile tested including the heart, brain, spleen, Gall bladder, lungs, liver, stomach, 148 
intestines, blood, cerebrospinal fluid, testis and copulatory organs, the results revealed that 149 
100 µg of sera, bile, gall bladder and heart lysates killed more than 60% PC-3 cells, however 150 
lung, intestine, and brain lysates showed partial cytotoxic effects (unpublished findings). 151 
When inoculated in fresh medium, PC3 cells treated with bile, gall bladder, sera, and heart 152 
lysates did not revive, while PC3 cells treated with lung, intestine and brain lysates exhibited 153 
partial growth. These findings  suggest that crocodile organ crude extracts contain active 154 
component(s) that affect the viability of PC3 cells. The broad-spectrum antitumor activity of 155 
various organ lysates of the crocodile against cancer and primary cells and the chemical 156 
identities of the active compound(s) are the subject of future studies. It is hoped that these 157 
molecules can eventually be developed into treatments against cancer that are becoming 158 
increasingly resistant to current available drugs. Crocodiles are one of the most ancient and 159 
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hardiest species that have survived millions of years. The ability of crocodiles to survive 160 
polluted environments together with the fact that crocodiles are an untapped source of 161 
pharmaceutical drug-leads, suggests such species may possess antitumor compound(s), 162 
endogenously and/or mechanisms to counter carcinogenic substance(s), however further work 163 
is needed to realize the potential of these findings.   164 
Snake venom has been tested for therapeutic interventions. Snake venom is made up 165 
of a mixture of biologically active components such as neurotoxins, myotoxins, enzymes, and 166 
pain inducing agents [34], some of which are shown to be of therapeutic value including 167 
captopril (derived from Bothrops jararaca) for renal dysfunction and exenatide (derived from 168 
Gila Monster lizard) for diabetes mellitus [34]. For anti-cancer properties, Phospholipase A2 169 
(PLA2) from snake venom was shown to induce apoptosis and inhibition of cell metastasis 170 
[35]. This was shown using BnSP-6, an isoform of PLA2 derived from the venom of 171 
Bothrops pauloensis that exhibited selective toxicity against MDA-MB-231 breast cancer 172 
cells in a dose-dependent manner with lower toxicity against normal breast epithelial cells 173 
(MCF10A) [35]. An acidic Asp49PLA2 known as MVL-PLA2, from the venom of 174 
Macrovipera lebetina also showed antitumor properties by inhibiting the adhesion and 175 
migration of melanoma cells (IGR39) [36]. The molecular mechanism of action of PLA2 176 
indicated that the hydrolytic activity of the PLA2 targeting the phospholipid membrane 177 
bilayer. The release of lysophospholipids (LysoPL) and fatty acids (FAs) from the membrane 178 
results in membrane damage, disruption of membrane surface proteins and cellular cascade 179 
functional disruption [34].. Ebrahim et al., [37] demonstrated the cytotoxic effects of 180 
cytotoxin, CTX-1 and CTX-11, derived from the Caspian Cobra (Naja oxiana), against 181 
tumour cells (liver adenocarcinoma, HepG2, and breast adenocarcinoma, MCF7 cells) and 182 
compared with the normal kidney cells (MDCK). It was shown that the cytotoxic effects are 183 
mediated via the lysosomal pathway and by entry of cathepsin into the cytosol [37]. Overall, 184 
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snake venom components such as CTX-1, CTX-11, BnSP-6 are shown to induce apoptosis 185 
[37] and inhibit cell adhesion and migration in cancer cell lines [35]. Cardiotoxin III from the 186 
venom of Naja naja atra demonstrated anti-metastatic properties against human breast cancer 187 
cells by suppressing the expression of hepatocyte growth factor (HGF)-induced c-Met 188 
phosphorylation [38]. Besides venom, studies are needed to test snake organ lysates for 189 
potential anti-tumour properties and the associated molecular mechanisms. For example, 190 
organ extracts of Cryptopodion scabrum, a geckonid lizard and Gekko swinhonis Guenther 191 
(GSPP) exhibited anti-proliferative activity and anti angiogenic effects against cancer cells 192 
selectively and in a dose- and time-dependent manner in vitro and in vivo [38,39]. It was 193 
demonstrated that cancer cells were unable to undergo metastasis due to disruption in bFGF 194 
function, a growth factor responsible for angiogenesis [38].  195 
 Among small mammals, several mechanisms have been proposed that may inhibit 196 
cancer development. For example, it was shown that Naked Mole Rats (NMRs; 197 
Heterocephalus glaber) exhibit changes in p53 gene [40], and their non-coding RNAs 198 
(IncRNAs) interact more with 4 types of high-molecular-mass hyaluronan (HMM-HA) from 199 
the fibroblasts compared to other rodents, which may enables them to inhibit cancer 200 
development [42-44]. Signals from HMM-HA triggers the activation of tumor suppressor 201 
INK4 (Inhibitors of cyclin-dependent kinase 4) locus expression [42-44]. This results in the 202 
activation of an alternate reading frame (ARF) and a novel product, pALTINK4a/b, which is a 203 
hybrid of the two tumor suppressor proteins, p15INK4b and p16INK4a. Interestingly, pALTINK4a/b 204 
were found to be present in NMRs but absent in humans, which suggests its role in the cancer 205 
resistance of NMRs [45]. On the other hand, an equilibrium between cell proliferation and 206 
cell death is essential. Extreme expression of cell proliferation proteins may result in 207 
tumorigenesis whereas extreme expression of tumor suppressor proteins will contribute in 208 
accelerated ageing. The tumor suppressor proteins, p15INK4b and p16INK4a, was also found to 209 
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be highly expressed in NMRs upon low levels of stress in addition to pALTINK4a/b which 210 
explains the reason NMRs do not develop cancer [42-46]. However, extreme tumor 211 
suppression activities accelerate ageing which is not the case among NMRs. Although many 212 
studies have been performed to discover the mechanism involved in NMR cancer resistance, 213 
[42-46] reported the presence of 2 NMRs with tumor. This finding showed that NMRs do 214 
develop cancer[47], albeit at a lower rate compared with humans. However, further studies 215 
are needed for  NMRs with cancer , to investigate the reliability of the anti-cancer mechanism 216 
which is believed to protect NMRs against tumorigenesis.  217 
Among Amphibians, the Bufonidae family which generally consists of  toad species 218 
were found to possess bioactive compounds with anti-cancer activities as well as other 219 
therapeutic activities such as anti-microbial and anti-allergy activities [48-49]. Bufonidae 220 
family are able to produce secretions from the parotids glands and skin which is rich in 221 
bioactive secondary metabolites with anti-cancer properties [50]. The secretion from the 222 
granular glands of the frog (Physalaemus nattereri) are poisonous and is normally used as a 223 
defense mechanism against predators. Studies have revealed the anti-cancer ability of the 224 
crude skin secretion containing this poisonous substance from Physalaemus nattereri against 225 
B16F10 murine melanoma cells [51,52].  The crude skin extracts were cytotoxic against 226 
murine melanoma cells in a concentration dependent manner via apoptosis and by cell cycle 227 
arrest at S phase [51,5242]. This was consistent with the findings by [52]. Cinobufacini 228 
compound from the skin of  Physalaemus nattereri significantly inhibited the growth of 229 
HepG2 via apoptosis, inducing cell cycle arrest at S phase and by downregulating the protein 230 
expression of TOPO 1 and TOPO II [51,52]. Later studies demonstrated the anti-cancer 231 
properties of skin extracts from the organisms belonging to the Bufonidae family [53]. The 232 
skin extract of the Bufo bufo gargarizans toad exhibited anti-cancer effects against human 233 
breast carcinoma cells by inducing apoptosis, cell cycle arrest and inhibiting metastasis via 234 
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the inhibition of cell migration and cell invasion of cancer cells [50-53]. The skin of the frog 235 
has been used since ancient times in Chinese Traditional Medicines such as Cinobufacini [51-236 
53]. This water soluble extract is a cancer treatment compound which used widely in China 237 
and approved by Chinese State Food and Drug Administration (SFDA) (ISO9002) [52]. The 238 
active compounds from Cinobufacini such as bufalin and resibufogenin were found to inhibit 239 
the proliferation of a wide range of cancer cell lines such as human hepatocellular carcinoma 240 
cells (HEPG2) and prostate adenocarcinoma cells (PC3) [50,52]. Studies also demonstrated 241 
the ability of this compound in inducing apoptosis among human hepatocellular carcinoma 242 
cells (SMMC-7721) and gastric carcinoma cells by decreasing the expression of certain anti-243 
apoptotic proteins such as Bcl-2 [52]. Notably, the majority of aforementioned studies have 244 
been conducted on human cells exposed to variety of cellular extracts from different 245 
organisms. Future studies are needed to test the effects of selected compounds in vitro using 246 
primary human cells of relevance as well as in vivo using relevant animal models.    247 
Compounds derived from animals are preferred for anti-tumour therapy as they are 248 
natural and can be readily synthesized. Being naturally-derived molecules, they are more 249 
tolerated and potentially non-toxic to normal human cells, albeit there are exceptions. If 250 
animals-derived drugs can demonstrate selectivity in research, are non-toxic to primary cells 251 
and show cytotoxicity to cancer cell lines, these drugs can be lead into clinical trials for 252 
further therapeutic development. Their potential mode of action is methytransferase 253 
inhibitors, DNA damage preventive drugs or antioxidants, histone deacetylases (HDAC) 254 
inhibitors and mitotic disruptors.  255 
In summary. this review is timely and topical and further investigation is warranted to 256 
explore various animals living in polluted environments as a large untapped source of 257 
pharmaceutical drug-leads that may lead to the identification of novel antitumor compound(s) 258 
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and/or mechanisms of cancer resistance for the rational development of therapeutic 259 
interventions.  260 
 261 
Compliance with Ethical Standards: 262 
Funding: This study was funded by Sunway University, Malaysia, grant FST-2015-05.   263 
Conflict of Interest: SJ declares that she has no conflict of interest. NAK declares that he has 264 
no conflict of interest. RS declares that she has no conflict of interest.  265 
Ethical approval: This article does not contain any studies with human participants performed 266 
by any of the authors.  267 
Ethical approval: This article does not contain any studies with animals performed by any of 268 
the authors.  269 
 270 
References 271 
1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, 272 
Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, 273 
methods and major patterns in GLOBOCAN 2012. Int J Can 136:359-386 274 
2. Global Cancer Facts & Figures (2017), American Cancer Society, viewed on 10th 275 
January 2017, < https://www.cancer.org/research/cancer-facts-statistics/global.html>. 276 
3. Rolston KVI (2017) Infections in Cancer Patients with Solid Tumors: A Review. 277 
Infect Dis Ther. doi: 10.1007/s40121-017-0146-1 (Epub ahead of print) 278 
 13 
 
4. Ehrhardt H, Pannert L, Pfeiffer S, Wachter F, Amtmann E, Jeremias I (2013) 279 
Enhanced anti-tumour effects of Vinca alkaloids given separately from cytostatic 280 
therapies. Br J Pharmacol 168:1558–1569 281 
5. Kang K, Oh SH, Yun JH, Jho EH, Kang JH, Batsuren D, Tunsag J, Park KH, Kim M, 282 
Nho CW (2011) A novel Topoisomerase inhibitor, Daurinol, suppresses growth of 283 
HCT116 cells with low Hematological toxicity compared to Etoposide. Neoplasia 284 
13:1043–IN30 285 
6. Kampan NC, Madondo MT, McNally OM, Quinn M, Plebanski M (2015) Paclitaxel 286 
and Its Evolving Role in the Management of Ovarian Cancer. BioMed Res Int 2015:1-287 
25 288 
7. Siddiqui R, Mansur S, Khan NA (2016) Do crocodiles and alligators hold the key to 289 
treat cancer? BMJ 354:i3763. 290 
8. Lehner AF, Rumbeiha W, Shlosberg A, Stuart K, Johnson M, Domenech R, Langner 291 
H (2013) Diagnostic analysis of veterinary dried blood spots for toxic heavy metals 292 
exposure. J Anal Toxicol 37:406-422 293 
9. Schneider L, Peleja RP, Kluczkovski A, Freire GM, Marioni B, Vogt PC, Da Silveira 294 
R (2012) Mercury concentration in the spectacled caiman and black caiman 295 
(Alligatoridae) of the Amazon: implications for human health. Arch Environ Contam 296 
Toxicol 63:270-279 297 
10. Rainwater TR, Millichamp NJ, Barrantes ID, Barr BR, Montero JR, Platt SG, Abel 298 
MT, Cobb GP, Anderson TA (2011) Ocular disease in American crocodiles 299 
(Crocodylus acutus) in Costa Rica. J Wildl Dis 47:415-426 300 
11. Vieira LM, Nunes Vda S, Amaral MC, Oliveira AC, Hauser-Davis RA, Campos RC 301 
(2010) Mercury and methyl mercury ratios in caimans (Caiman crocodilus yacare) 302 
from the Pantanal area Brazil. J Environ Monitor 13:280-287 303 
 14 
 
12. Campbell JW, Waters MN, Tarter A, Jackson J (2010) Heavy metal and selenium 304 
concentrations in liver tissue from wild American alligator (Alligator 305 
mississippiensis) livers near Charleston, South Carolina. J Wildlife Dis 46:1234-41 306 
13. Janke A, Gullberg A, Hughes S, Aggarwal RK, Arnason U (2005) Mitogenomic 307 
analyses place the gharial (Gavialis gangeticus) on the crocodile tree and provide pre-308 
K/T divergence times for most crocodilians. J Mol Evol 61:620-626 309 
14. Colbert EH (1997) The Age of Reptiles. Generating Publishing Company (ISBN 0-310 
486-29377-7) 311 
15. Dietz J, Heckers KO, Aupperle H, Pees M (2016) Cutaneous and Subcutaneous Soft 312 
Tissue Tumours in Snakes: A Retrospective Study of 33 Cases. J Comp Pathol 155: 313 
76-87 314 
16.  Eyarefe OD, Antia RE, Oguntoye CO, Abiola OO Alaka OO and Ogunsola JO 315 
(2012) Rhabdomyosarcoma in a terrestrial tortoise (Geochelone nigra) in Nigeria: a 316 
case report. J South Afr Vet Assoc 83: doi: 10.4102/jsava.v83i1.300 317 
17. Janert B (1998) A fibrosarcoma in a Siamese crocodile (Crocodylus siamensis). J Zoo 318 
Wildlife Med 29: 72-77 319 
18. Martorell J, Ramis A and Espada Y (2002) Use of ultrasonography in the diagnosis of 320 
hepatic spindle-cell sarcoma in a savannah monitor (Varanus exanthematicus). Vet 321 
Rec 150: 282-284 322 
19. Leone A, Dark M, Kondo H, Rotstein DS, Kiupel M, Walsh MT, Erlacher-Reid C, 323 
Gordon N, Conway JA (2013) Gastrointestinal leiomyosarcoma in a pygmy sperm 324 
whale (Kogia breviceps). J Zoo Wildlife Med 44: 744-748 325 
20. Manire CA, Clarke AC, Wert D, Landolfi J (2013) Lymphosarcoma in a captive 326 
bonnethead shark, Sphyrna tiburo (L.). J Fish Dis 36: 437-440 327 
 15 
 
21. Sulak M, Fong L, Mika K, Chigurupati S, Yon L, Mongan NP, Emes RD, Lynch VJ 328 
(2016) TP53 copy number expansion is associated with the evolution of increased 329 
body size and an enhanced DNA damage response in elephants. eLife. doi: 330 
10.7554/eLife.11994 (Epub ahead of print) 331 
22. Keane M, Semeiks J, Webb AE, Li Y, Quesada V, Craig T, Madsen LB, van Dam S, 332 
Brawand D, Marques PI, Michalak P, Kang L, Bhak J, Yim HS, Grishin NV, Nielsen 333 
NH, Heide-Jørgensen MP, Oziolor EM, Matson CW, Church GM, Stuart GW, Patton 334 
JC, George JC, Suydam R, Larsen K, López-Otín C, O'Connell MJ, Bickham JW, 335 
Thomsen B, de Magalhães JP (2015) Insights into the evolution of longevity from the 336 
bowhead whale genome. Cell Rep 10:112-122 337 
23. Abegglen LM, Caulin AF, Chan A, Lee K, Robinson R, Campbell MS, Kiso WK, 338 
Schmitt DL, Waddell PJ, Bhaskara S, Jensen ST, Maley CC, Schiffman JD (2015) 339 
Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular 340 
Response to DNA Damage in Humans. JAMA 314:1850-1860 341 
24. Patathananone S, Thammasirirak S, Daduang J, Gung CJ, Temsiripong Y, Daduang S 342 
(2016) Inhibition of HeLa cells metastasis by bioactive compounds in crocodile 343 
(Crocodylus siamensis) white blood cells extract. Environ Toxicol 31:1329-1336 344 
25. Patathananone S, Thammasirirak S, Daduang J, Chung JG, Temsiripong Y and 345 
Daduang S (2016) Bioactive compounds from crocodile (Crocodylus siamensis) white 346 
blood cells induced apoptotic cell death in hela cells. Environ Toxicol 31:986-997 347 
26. Theansongnoen T, Maijaroen S, Jangpromma N, Yaraksa N, Daduang S, Temsiripong 348 
T, Daduang J, Klaynongsruang S (2016) Cationic Antimicrobial Peptides Derived 349 
from Crocodylus siamensis Leukocyte Extract, Revealing Anticancer Activity and 350 
Apoptotic Induction on Human Cervical Cancer Cells. Protein J 35:202-211 351 
 16 
 
27. Song W, Shen DY, Kang JH, Li SS, Zhan HW, Shi Y, Xiong YX, Liang G, Chen QX 352 
(2012) Apoptosis of human cholangiocarcinoma cells induced by ESC-3 from 353 
Crocodylus siamensis bile. World J Gastroenterol 18:704-711 354 
28. Wang DQ, Carey MC (2014) Therapeutic uses of animal biles in traditional Chinese 355 
medicine: an ethnopharmacological, biophysical chemical and medicinal review. 356 
World J Gastroenterol 20: 9952-9975 357 
29. Kang JH, Zhang WQ, Song W, Shen DY, Li SS, Tian L, Shi Y, Liang G, Xiong YX, 358 
Chen QX (2012) Apoptosis Mechanism of Human Cholangiocarcinoma Cells Induced 359 
by Bile Extract from Crocodile. Appl Biochem Biotechnol 166:942-951 360 
30. Song W, Li SS, Qiu PP, Shen DY, Tian L, Zhang QY, Liao LX, Chen QX (2013) 361 
Apoptosis Induced by Aqueous Extracts of Crocodile Bile in Human Heptacarcinoma 362 
SMMC-7721. Appl Biochem Biotechnol 170:15-24 363 
31. Shen DY, Zhang W, Zeng X, Liu CQ (2013) Inhibition of Wnt⁄b-catenin signaling 364 
downregulates P-glycoprotein and reverses multi-drug resistance of 365 
cholangiocarcinoma. JCA 104:1303-1308 366 
32. Albert DS, Martinez ME, Hess LM, Einspahr JG, Green SB, Bhattacharyya AK, 367 
Guillen J, Krutzsch M, Batta AK, Salen G, Fales L, Koonce K, Parish D, Clouser M, 368 
Roe D, Lance P (2005) Phase III trial of ursodeoxycholic acid to prevent colorectal 369 
adenoma recurrence. J Natl Cancer Inst 97:846-853 370 
33. Ajouz H, Mukherji D, Shamseddine A (2014) Secondary bile acids: an 371 
underrecognized cause of colon cancer. World J Surg Oncol. doi: 10.1186/1477-7819-372 
12-164 (Epub ahead of print) 373 
34. Chaisakul J, Hodgson WC, Kuruppu S, Prasongsook N (2016) Effects of Animal 374 
Venoms and Toxins on Hallmarks of Cancer. J Ca 7:1571-1578. 375 
 17 
 
35. Azevedo FV, Lopes DS, Cirilo Gimenes SN, Achê DC, Vecchi L, Alves PT, 376 
Guimarães Dde O, Rodrigues RS, Goulart LR, Rodrigues Vde M, Yoneyama KA 377 
(2016) Human breast cancer cell death induced by BnSP-6, a Lys-49 PLA₂ 378 
homologue from Bothrops pauloensis venom. Int J Biol Macromolec 82:671-677 379 
36. Bazaa A, Luis J, Srairi-Abid N, Kallech-Ziri O, Kessentini-Zouari  R, Defilles C, 380 
Lissitzky JC, El Ayeb M, Marrakchi N (2009) MVL-PLA2, a phospholipase A2 from 381 
Macrovipera lebetina transmediterranea venom, inhibits tumor cells adhesion and 382 
migration. Matrix Biol 28:188-193 383 
37. Ebrahim K, Shirazi FH, Mirakabadi AZ, Vatanpour H (2015) Cobra venom 384 
cytotoxins; apoptotic or necrotic agents?. Toxicon 108:134-140 385 
38. Tsai PC, Chu CL, Chiu CC, Chang LS, Lin SR (2014) Cardiotoxin III suppresses 386 
hepatocyte growth factor-stimulated migration and invasion of MDA-MB-231 cells. 387 
Cell Biochem Funct 32:485-495 388 
39. Ding XL, Man YN, Hao J, Zhu CH, Liu C, Yang X, Wu XZ (2016) The Antitumor 389 
Effect of Gekko Sulfated Glycopeptide by Inhibiting bFGF-Induced 390 
Lymphangiogenesis. Biomed Res Int. doi: 10.1155/2016/7396392 (Epub ahead of 391 
print) 392 
40. Keane M, Craig T, Alföldi J, Berlin AM, Johnson J, Seluanov A, Gorbunova V, Di 393 
Palma F, Lindblad-Toh K, Church GM, de Magalhães JP (2014). The Naked Mole 394 
Rat Genome Resource: facilitating analyses of cancer and longevity-related 395 
adaptations. Bioinformatics 30:3558-3560.  396 
41. Tian X1, Azpurua J, Hine C, Vaidya A, Myakishev-Rempel M, Ablaeva J, Mao Z, 397 
Nevo E, Gorbunova V, Seluanov A (2013) High-molecular-mass hyaluronan mediates 398 
the cancer resistance of the naked mole rat. Nature 499(7458):346-349.  399 
 18 
 
42. Amiri A, Namavari M, Rashidi M, Fahmidekhar MA, Seghatoleslam A (2015) 400 
Inhibitory effects of Cyrtopodion scabrum extract on growth of human breast and 401 
colorectal cancer cells. APJCP 16:565-570 402 
43. Zhang SX, Zhu C, Ba Y, Chen D, Zhou XL, Cao R, Wang LP, Ren Y, Wu XZ (2012) 403 
Gekko-sulfated glycopeptide inhibits tumor angiogenesis by targeting basic fibroblast 404 
growth factor. J Biol Chem 287:13206-13215 405 
44. Jiang JJ, Cheng LH, Wu H, He YH, Kong QP (2016) Insights into long noncoding 406 
RNAs of naked mole rat (Heterocephalus glaber) and their potential association with 407 
cancer resistance. Epigenetics Chromatin 9:1-10 408 
45. Piersigilli A, Meyerholz DK (2016) The ‘‘Naked Truth’’: Naked Mole-Rats Do Get 409 
Cancer. Vet Pathol 53:519-520 410 
46. Tian X, Azpurua J, Ke Z, Augereau A, Zhang ZD, Vijg J, Gladyshev VN, Gorbunova 411 
V, Seluanov A (2014) INK4 locus of the tumor-resistant rodent, the naked mole rat, 412 
expresses a functional p15/p16 hybrid isoform. PNAS 112:1053-1058 413 
47. Taylor KR, Milone NA, Rodriguez CE (2017) Four Cases of Spontaneous Neoplasia 414 
in the Naked MoleRat (Heterocephalus glaber), A Putative Cancer-Resistant Species. 415 
J Gerontol A Bio Sci 72:38-43  416 
48. Gonzales JA, Amich F, Postigo-Mota S, Vallejo JR (2016) The use of wild 417 
vertebrates in contemporary Spanish ethno veterinary medicine. J Ethnopharmacol 418 
191:135-151 419 
49. Rodriguez C, Rollins-Smith L, Ibanez R, Durant-Archibold AA, Gutierrez M (2016) 420 
Toxins and pharmacologically active compounds from species of the family 421 
Bufonidae (Amphibia, Anura). J Ethnopharmacol. doi: 10.1016/j.jep.2016.12.021 422 
(Epub ahead of print) 423 
 19 
 
50. Cruz e Carvalho A, Márquez CA, Azevedo RB, Joanitti GA, Pires Júnior OR, Fontes 424 
W, Castro MS (2015) Cytotoxic Activity and Antiproliferative Effects of Crude Skin 425 
Secretion from Physalaemus nattereri (Anura: Leptodactylidae) on in vitro Melanoma 426 
Cells. Toxins 7:3989-4005 427 
51. Liu Y, Ban LY, Su X, Gao S, Liu JW, Cui XN (2015) Effects of cinobufacini 428 
injection on cell proliferation and the expression of topoisomerases in human HepG-2 429 
hepatocellular carcinoma cells. Mol Med Rep 12:1598-1604 430 
52. Nakata M, Mori S, Kamoshida Y, Kawaguchi S, Fujita-Yamaguchi Y, Gao B, Tang 431 
W (2015) Toad skin extract cinobufatini inhibits migration of human breast 432 
carcinoma MDA-MB-231 cells into a model stromal tissue. Biosci Trends 9:266-269 433 
53. Qi F, Inagaki Y, Kokudo N, Tamura S, Nakata M, Tang W (2011) Antitumor activity 434 
of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor. 435 
Inter Pharmacol 11:342-349 436 
